Index by author

01 May 2003; volume 21, issue 5

A

  1. Aoike, N.

    1. Hoshino, M. et al "Increased immunoreactivity of stromal cell-derived factor‐1 and angiogenesis in asthma." European Respiratory Journal 21.5 (2003): 804-809. Web. 27 June. 2022.

  2. Ardite, E.

    1. Rabinovich, R.A. et al "Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients." European Respiratory Journal 21.5 (2003): 789-794. Web. 27 June. 2022.

  3. Argilés, J.M.

    1. Rabinovich, R.A. et al "Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients." European Respiratory Journal 21.5 (2003): 789-794. Web. 27 June. 2022.

  4. Arif, A.A.

    1. Arif, A.A. et al "Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data." European Respiratory Journal 21.5 (2003): 827-833. Web. 27 June. 2022.

  5. Atis, S.

    1. Nayci, A. et al "Rigid bronchoscopy induces bacterial translocation: an experimental study in rats." European Respiratory Journal 21.5 (2003): 749-752. Web. 27 June. 2022.

B

  1. Balfour-Lynn, I.

    1. Chavasse, R. et al "To clip or not to clip? Noseclips for spirometry." European Respiratory Journal 21.5 (2003): 876-878. Web. 27 June. 2022.

  2. Barberà, J.A.

    1. Rabinovich, R.A. et al "Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients." European Respiratory Journal 21.5 (2003): 789-794. Web. 27 June. 2022.
    2. Barberà, J.A., V.I. Peinado, and S. Santos. "Pulmonary hypertension in chronic obstructive pulmonary disease." European Respiratory Journal 21.5 (2003): 892-905. Web. 27 June. 2022.

  3. Barros, H.

    1. Rocha, M. et al "The role of adherence in tuberculosis HIV‐positive patients treated in ambulatory regimen." European Respiratory Journal 21.5 (2003): 785-788. Web. 27 June. 2022.

  4. Bernstein, D.

    1. Moscato, G., J-L. Malo, and D. Bernstein. "Diagnosing occupational asthma: how, how much, how far?." European Respiratory Journal 21.5 (2003): 879-885. Web. 27 June. 2022.

  5. Bíbová, J.

    1. Hampl, V. et al "Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats." European Respiratory Journal 21.5 (2003): 862-865. Web. 27 June. 2022.

  6. Boel, M.

    1. Gracchi, V. et al "Spirometry in young children: should computer-animation programs be used during testing?." European Respiratory Journal 21.5 (2003): 872-875. Web. 27 June. 2022.

  7. Bush, A.

    1. Chavasse, R. et al "To clip or not to clip? Noseclips for spirometry." European Respiratory Journal 21.5 (2003): 876-878. Web. 27 June. 2022.

  8. Büttner, C.

    1. Büttner, C. et al "Monoclonal anti-interleukin‐5 treatment suppresses eosinophil but not T‐cell functions." European Respiratory Journal 21.5 (2003): 799-803. Web. 27 June. 2022.

C

  1. Carbó, N.

    1. Rabinovich, R.A. et al "Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients." European Respiratory Journal 21.5 (2003): 789-794. Web. 27 June. 2022.

  2. Chavasse, R.

    1. Chavasse, R. et al "To clip or not to clip? Noseclips for spirometry." European Respiratory Journal 21.5 (2003): 876-878. Web. 27 June. 2022.

  3. Cook, S.

    1. Cook, S. et al "Increased eNO and pulmonary iNOS expression in eNOS null mice." European Respiratory Journal 21.5 (2003): 770-773. Web. 27 June. 2022.

  4. Cowan, J.O.

    1. Wraight, J.M. et al "Bronchodilator tolerance: the impact of increasing bronchoconstriction." European Respiratory Journal 21.5 (2003): 810-815. Web. 27 June. 2022.

D

  1. De Carolis, E.

    1. Marrie, T.J. et al "Chlamydia species as a cause of community-acquired pneumonia in Canada." European Respiratory Journal 21.5 (2003): 779-784. Web. 27 June. 2022.

  2. Delclos, G.L.

    1. Arif, A.A. et al "Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data." European Respiratory Journal 21.5 (2003): 827-833. Web. 27 June. 2022.

  3. De Mey, J.

    1. Meysman, M. et al "Recurrent tracheal mass." European Respiratory Journal 21.5 (2003): 906-908. Web. 27 June. 2022.

  4. Dik, W.A.

    1. Dik, W.A. et al "Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity." European Respiratory Journal 21.5 (2003): 842-847. Web. 27 June. 2022.

  5. Dimakou, K.

    1. Koulouris, N.G. et al "Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis." European Respiratory Journal 21.5 (2003): 743-748. Web. 27 June. 2022.

  6. Dolovich, M.B.

    1. Labiris, N.R. et al "Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?." European Respiratory Journal 21.5 (2003): 848-854. Web. 27 June. 2022.

E

  1. Ediger, T.L.

    1. Ediger, T.L. et al "Transcription factor activation and mitogenic synergism in airway smooth muscle cells." European Respiratory Journal 21.5 (2003): 759-769. Web. 27 June. 2022.

  2. Egli, M.

    1. Cook, S. et al "Increased eNO and pulmonary iNOS expression in eNOS null mice." European Respiratory Journal 21.5 (2003): 770-773. Web. 27 June. 2022.

  3. Ersoz, G.

    1. Nayci, A. et al "Rigid bronchoscopy induces bacterial translocation: an experimental study in rats." European Respiratory Journal 21.5 (2003): 749-752. Web. 27 June. 2022.

  4. Evans, T.W.

    1. Jones, A.T., D.M. Hansell, and T.W. Evans. "Pulmonary perfusion quantified by electron-beam computed tomography: effects of hypoxia and inhaled NO." European Respiratory Journal 21.5 (2003): 855-861. Web. 27 June. 2022.

  5. Ewig, S.

    1. Woodhead, M., S. Ewig, and A. Torres. "Severe acute respiratory syndrome (SARS)." European Respiratory Journal 21.5 (2003): 739-740. Web. 27 June. 2022.
    2. Ewig, S., and A. Torres. "Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?." European Respiratory Journal 21.5 (2003): 741-742. Web. 27 June. 2022.

F

  1. Fernandez-Checa, J.C.

    1. Rabinovich, R.A. et al "Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients." European Respiratory Journal 21.5 (2003): 789-794. Web. 27 June. 2022.

  2. Ferreira, L.

    1. Rocha, M. et al "The role of adherence in tuberculosis HIV‐positive patients treated in ambulatory regimen." European Respiratory Journal 21.5 (2003): 785-788. Web. 27 June. 2022.

  3. Figueras, M.

    1. Rabinovich, R.A. et al "Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients." European Respiratory Journal 21.5 (2003): 789-794. Web. 27 June. 2022.

  4. Filella, X.

    1. Rabinovich, R.A. et al "Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients." European Respiratory Journal 21.5 (2003): 789-794. Web. 27 June. 2022.

  5. Flannery, E.M.

    1. Wraight, J.M. et al "Bronchodilator tolerance: the impact of increasing bronchoconstriction." European Respiratory Journal 21.5 (2003): 810-815. Web. 27 June. 2022.

  6. Forster, J.

    1. Lau, S. et al "Transient early wheeze is not associated with impaired lung function in 7‐yr-old children." European Respiratory Journal 21.5 (2003): 834-841. Web. 27 June. 2022.

  7. Francis, J.

    1. Chavasse, R. et al "To clip or not to clip? Noseclips for spirometry." European Respiratory Journal 21.5 (2003): 876-878. Web. 27 June. 2022.

  8. Freitag, A.P.

    1. Labiris, N.R. et al "Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?." European Respiratory Journal 21.5 (2003): 848-854. Web. 27 June. 2022.

  9. Fujikane, T.

    1. Nishigaki, Y. et al "Increased vascular endothelial growth factor in acute eosinophilic pneumonia." European Respiratory Journal 21.5 (2003): 774-778. Web. 27 June. 2022.

  10. Fujita, Y.

    1. Nishigaki, Y. et al "Increased vascular endothelial growth factor in acute eosinophilic pneumonia." European Respiratory Journal 21.5 (2003): 774-778. Web. 27 June. 2022.

  11. Fujiuchi, S.

    1. Nishigaki, Y. et al "Increased vascular endothelial growth factor in acute eosinophilic pneumonia." European Respiratory Journal 21.5 (2003): 774-778. Web. 27 June. 2022.

G

  1. Gerrits, C.M.J.M.

    1. Gerrits, C.M.J.M. et al "N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease." European Respiratory Journal 21.5 (2003): 795-798. Web. 27 June. 2022.

  2. Godtfredsen, N.

    1. Prescott, E. et al "Social position and mortality from respiratory diseases in males and females." European Respiratory Journal 21.5 (2003): 821-826. Web. 27 June. 2022.

  3. Gracchi, V.

    1. Gracchi, V. et al "Spirometry in young children: should computer-animation programs be used during testing?." European Respiratory Journal 21.5 (2003): 872-875. Web. 27 June. 2022.

  4. Grüber, C.

    1. Lau, S. et al "Transient early wheeze is not associated with impaired lung function in 7‐yr-old children." European Respiratory Journal 21.5 (2003): 834-841. Web. 27 June. 2022.

H

  1. Hampl, V.

    1. Hampl, V. et al "Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats." European Respiratory Journal 21.5 (2003): 862-865. Web. 27 June. 2022.

  2. Hancox, R.J.

    1. Wraight, J.M. et al "Bronchodilator tolerance: the impact of increasing bronchoconstriction." European Respiratory Journal 21.5 (2003): 810-815. Web. 27 June. 2022.

  3. Hansell, A.

    1. Hansell, A.. "Efficacy of acupuncture in asthma." European Respiratory Journal 21.5 (2003): 909. Web. 27 June. 2022.

  4. Hansell, D.M.

    1. Jones, A.T., D.M. Hansell, and T.W. Evans. "Pulmonary perfusion quantified by electron-beam computed tomography: effects of hypoxia and inhaled NO." European Respiratory Journal 21.5 (2003): 855-861. Web. 27 June. 2022.

  5. Herbison, G.P.

    1. Wraight, J.M. et al "Bronchodilator tolerance: the impact of increasing bronchoconstriction." European Respiratory Journal 21.5 (2003): 810-815. Web. 27 June. 2022.

  6. Herget, J.

    1. Hampl, V. et al "Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats." European Respiratory Journal 21.5 (2003): 862-865. Web. 27 June. 2022.

  7. Herings, R.M.C.

    1. Gerrits, C.M.J.M. et al "N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease." European Respiratory Journal 21.5 (2003): 795-798. Web. 27 June. 2022.

  8. Holgate, S.T.

    1. Zhang, J. et al "From the Authors." European Respiratory Journal 21.5 (2003): 910. Web. 27 June. 2022.

  9. Hoshino, M.

    1. Hoshino, M. et al "Increased immunoreactivity of stromal cell-derived factor‐1 and angiogenesis in asthma." European Respiratory Journal 21.5 (2003): 804-809. Web. 27 June. 2022.

  10. Huuskonen, M.S.

    1. Vehmas, T. et al "Effects of tobacco smoking on findings in chest computed tomography among asbestos-exposed workers." European Respiratory Journal 21.5 (2003): 866-871. Web. 27 June. 2022.

I

  1. Illi, S.

    1. Lau, S. et al "Transient early wheeze is not associated with impaired lung function in 7‐yr-old children." European Respiratory Journal 21.5 (2003): 834-841. Web. 27 June. 2022.

J

  1. Jaakkola, M.S.

    1. Vehmas, T. et al "Effects of tobacco smoking on findings in chest computed tomography among asbestos-exposed workers." European Respiratory Journal 21.5 (2003): 866-871. Web. 27 June. 2022.

  2. Janssen, D.J.

    1. Dik, W.A. et al "Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity." European Respiratory Journal 21.5 (2003): 842-847. Web. 27 June. 2022.

  3. Johnson, P.

    1. Chavasse, R. et al "To clip or not to clip? Noseclips for spirometry." European Respiratory Journal 21.5 (2003): 876-878. Web. 27 June. 2022.

  4. Jones, A.T.

    1. Jones, A.T., D.M. Hansell, and T.W. Evans. "Pulmonary perfusion quantified by electron-beam computed tomography: effects of hypoxia and inhaled NO." European Respiratory Journal 21.5 (2003): 855-861. Web. 27 June. 2022.

  5. Jordanoglou, J.

    1. Koulouris, N.G. et al "Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis." European Respiratory Journal 21.5 (2003): 743-748. Web. 27 June. 2022.

K

  1. Kikuchi, K.

    1. Nishigaki, Y. et al "Increased vascular endothelial growth factor in acute eosinophilic pneumonia." European Respiratory Journal 21.5 (2003): 774-778. Web. 27 June. 2022.

  2. Kivisaari, L.

    1. Vehmas, T. et al "Effects of tobacco smoking on findings in chest computed tomography among asbestos-exposed workers." European Respiratory Journal 21.5 (2003): 866-871. Web. 27 June. 2022.

  3. Kosmas, E.

    1. Koulouris, N.G. et al "Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis." European Respiratory Journal 21.5 (2003): 743-748. Web. 27 June. 2022.

  4. Koulouris, N.G.

    1. Koulouris, N.G. et al "Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis." European Respiratory Journal 21.5 (2003): 743-748. Web. 27 June. 2022.

  5. Koutsoukou, A.

    1. Koulouris, N.G. et al "Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis." European Respiratory Journal 21.5 (2003): 743-748. Web. 27 June. 2022.

  6. Kunkel, G.

    1. Büttner, C. et al "Monoclonal anti-interleukin‐5 treatment suppresses eosinophil but not T‐cell functions." European Respiratory Journal 21.5 (2003): 799-803. Web. 27 June. 2022.

L

  1. Labiris, N.R.

    1. Labiris, N.R. et al "Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?." European Respiratory Journal 21.5 (2003): 848-854. Web. 27 June. 2022.

  2. Lammers, J-W.J.

    1. Gerrits, C.M.J.M. et al "N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease." European Respiratory Journal 21.5 (2003): 795-798. Web. 27 June. 2022.

  3. Lau, S.

    1. Lau, S. et al "Transient early wheeze is not associated with impaired lung function in 7‐yr-old children." European Respiratory Journal 21.5 (2003): 834-841. Web. 27 June. 2022.

  4. Lee, E.S.

    1. Arif, A.A. et al "Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data." European Respiratory Journal 21.5 (2003): 827-833. Web. 27 June. 2022.

  5. Leufkens, H.G.M.

    1. Gerrits, C.M.J.M. et al "N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease." European Respiratory Journal 21.5 (2003): 795-798. Web. 27 June. 2022.

  6. Lun, A.

    1. Büttner, C. et al "Monoclonal anti-interleukin‐5 treatment suppresses eosinophil but not T‐cell functions." European Respiratory Journal 21.5 (2003): 799-803. Web. 27 June. 2022.

M

  1. Madloch, C.

    1. Lau, S. et al "Transient early wheeze is not associated with impaired lung function in 7‐yr-old children." European Respiratory Journal 21.5 (2003): 834-841. Web. 27 June. 2022.

  2. Malagari, K.

    1. Koulouris, N.G. et al "Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis." European Respiratory Journal 21.5 (2003): 743-748. Web. 27 June. 2022.

  3. Malo, J-L.

    1. Moscato, G., J-L. Malo, and D. Bernstein. "Diagnosing occupational asthma: how, how much, how far?." European Respiratory Journal 21.5 (2003): 879-885. Web. 27 June. 2022.

  4. Mantzikopoulos, G.

    1. Koulouris, N.G. et al "Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis." European Respiratory Journal 21.5 (2003): 743-748. Web. 27 June. 2022.

  5. Marrie, T.J.

    1. Marrie, T.J. et al "Chlamydia species as a cause of community-acquired pneumonia in Canada." European Respiratory Journal 21.5 (2003): 779-784. Web. 27 June. 2022.

  6. Martin, B.

    1. Mascaux, C. et al "Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53." European Respiratory Journal 21.5 (2003): 753-758. Web. 27 June. 2022.

  7. Mascaux, C.

    1. Mascaux, C. et al "Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53." European Respiratory Journal 21.5 (2003): 753-758. Web. 27 June. 2022.

  8. Matsumoto, H.

    1. Nishigaki, Y. et al "Increased vascular endothelial growth factor in acute eosinophilic pneumonia." European Respiratory Journal 21.5 (2003): 774-778. Web. 27 June. 2022.

  9. McKendrick, M.

    1. Mohsen, A.H., and M. McKendrick. "Varicella pneumonia in adults." European Respiratory Journal 21.5 (2003): 886-891. Web. 27 June. 2022.

  10. Meert, A.P.

    1. Mascaux, C. et al "Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53." European Respiratory Journal 21.5 (2003): 753-758. Web. 27 June. 2022.

  11. Ménard, B.

    1. Cook, S. et al "Increased eNO and pulmonary iNOS expression in eNOS null mice." European Respiratory Journal 21.5 (2003): 770-773. Web. 27 June. 2022.

  12. Meysman, M.

    1. Meysman, M. et al "Recurrent tracheal mass." European Respiratory Journal 21.5 (2003): 906-908. Web. 27 June. 2022.

  13. Milic-Emili, J.

    1. Koulouris, N.G. et al "Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis." European Respiratory Journal 21.5 (2003): 743-748. Web. 27 June. 2022.

  14. Mohsen, A.H.

    1. Mohsen, A.H., and M. McKendrick. "Varicella pneumonia in adults." European Respiratory Journal 21.5 (2003): 886-891. Web. 27 June. 2022.

  15. Moscato, G.

    1. Moscato, G., J-L. Malo, and D. Bernstein. "Diagnosing occupational asthma: how, how much, how far?." European Respiratory Journal 21.5 (2003): 879-885. Web. 27 June. 2022.

  16. Murphy, T.J.

    1. Ediger, T.L. et al "Transcription factor activation and mitogenic synergism in airway smooth muscle cells." European Respiratory Journal 21.5 (2003): 759-769. Web. 27 June. 2022.

N

  1. Naber, B.A.

    1. Dik, W.A. et al "Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity." European Respiratory Journal 21.5 (2003): 842-847. Web. 27 June. 2022.

  2. Nahmias, C.

    1. Labiris, N.R. et al "Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?." European Respiratory Journal 21.5 (2003): 848-854. Web. 27 June. 2022.

  3. Nakagawa, T.

    1. Hoshino, M. et al "Increased immunoreactivity of stromal cell-derived factor‐1 and angiogenesis in asthma." European Respiratory Journal 21.5 (2003): 804-809. Web. 27 June. 2022.

  4. Nakamura, Y.

    1. Hoshino, M. et al "Increased immunoreactivity of stromal cell-derived factor‐1 and angiogenesis in asthma." European Respiratory Journal 21.5 (2003): 804-809. Web. 27 June. 2022.

  5. Nayci, A.

    1. Nayci, A. et al "Rigid bronchoscopy induces bacterial translocation: an experimental study in rats." European Respiratory Journal 21.5 (2003): 749-752. Web. 27 June. 2022.

  6. Newhouse, M.T.

    1. Newhouse, M.T., P. Patel, and M. Parry-Billings. "Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler® DPI." European Respiratory Journal 21.5 (2003): 816-820. Web. 27 June. 2022.

  7. Nickel, R.

    1. Lau, S. et al "Transient early wheeze is not associated with impaired lung function in 7‐yr-old children." European Respiratory Journal 21.5 (2003): 834-841. Web. 27 June. 2022.

  8. Nicod, P.

    1. Cook, S. et al "Increased eNO and pulmonary iNOS expression in eNOS null mice." European Respiratory Journal 21.5 (2003): 770-773. Web. 27 June. 2022.

  9. Niggemann, B.

    1. Lau, S. et al "Transient early wheeze is not associated with impaired lung function in 7‐yr-old children." European Respiratory Journal 21.5 (2003): 834-841. Web. 27 June. 2022.

  10. Ninane, V.

    1. Mascaux, C. et al "Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53." European Respiratory Journal 21.5 (2003): 753-758. Web. 27 June. 2022.

  11. Nishigaki, Y.

    1. Nishigaki, Y. et al "Increased vascular endothelial growth factor in acute eosinophilic pneumonia." European Respiratory Journal 21.5 (2003): 774-778. Web. 27 June. 2022.

  12. Noppen, M.

    1. Meysman, M. et al "Recurrent tracheal mass." European Respiratory Journal 21.5 (2003): 906-908. Web. 27 June. 2022.

O

  1. Okamoto, K.

    1. Nishigaki, Y. et al "Increased vascular endothelial growth factor in acute eosinophilic pneumonia." European Respiratory Journal 21.5 (2003): 774-778. Web. 27 June. 2022.

  2. Osler, M.

    1. Prescott, E. et al "Social position and mortality from respiratory diseases in males and females." European Respiratory Journal 21.5 (2003): 821-826. Web. 27 June. 2022.

P

  1. Parry-Billings, M.

    1. Newhouse, M.T., P. Patel, and M. Parry-Billings. "Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler® DPI." European Respiratory Journal 21.5 (2003): 816-820. Web. 27 June. 2022.

  2. Patel, P.

    1. Newhouse, M.T., P. Patel, and M. Parry-Billings. "Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler® DPI." European Respiratory Journal 21.5 (2003): 816-820. Web. 27 June. 2022.

  3. Peeling, R.W.

    1. Marrie, T.J. et al "Chlamydia species as a cause of community-acquired pneumonia in Canada." European Respiratory Journal 21.5 (2003): 779-784. Web. 27 June. 2022.

  4. Peinado, V.I.

    1. Barberà, J.A., V.I. Peinado, and S. Santos. "Pulmonary hypertension in chronic obstructive pulmonary disease." European Respiratory Journal 21.5 (2003): 892-905. Web. 27 June. 2022.

  5. Pereira, S.

    1. Rocha, M. et al "The role of adherence in tuberculosis HIV‐positive patients treated in ambulatory regimen." European Respiratory Journal 21.5 (2003): 785-788. Web. 27 June. 2022.

  6. Pipeleers-Marichal, M.

    1. Meysman, M. et al "Recurrent tracheal mass." European Respiratory Journal 21.5 (2003): 906-908. Web. 27 June. 2022.

  7. Povýšilová, V.

    1. Hampl, V. et al "Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats." European Respiratory Journal 21.5 (2003): 862-865. Web. 27 June. 2022.

  8. Prescott, E.

    1. Prescott, E. et al "Social position and mortality from respiratory diseases in males and females." European Respiratory Journal 21.5 (2003): 821-826. Web. 27 June. 2022.

R

  1. Rabinovich, R.A.

    1. Rabinovich, R.A. et al "Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients." European Respiratory Journal 21.5 (2003): 789-794. Web. 27 June. 2022.

  2. Reid, T.

    1. Marrie, T.J. et al "Chlamydia species as a cause of community-acquired pneumonia in Canada." European Respiratory Journal 21.5 (2003): 779-784. Web. 27 June. 2022.

  3. Reiss, T.F.

    1. Zhang, J. et al "From the Authors." European Respiratory Journal 21.5 (2003): 910. Web. 27 June. 2022.

  4. Renz, H.

    1. Büttner, C. et al "Monoclonal anti-interleukin‐5 treatment suppresses eosinophil but not T‐cell functions." European Respiratory Journal 21.5 (2003): 799-803. Web. 27 June. 2022.

  5. Retsou, S.

    1. Koulouris, N.G. et al "Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis." European Respiratory Journal 21.5 (2003): 743-748. Web. 27 June. 2022.

  6. Roca, J.

    1. Rabinovich, R.A. et al "Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients." European Respiratory Journal 21.5 (2003): 789-794. Web. 27 June. 2022.

  7. Rocha, M.

    1. Rocha, M. et al "The role of adherence in tuberculosis HIV‐positive patients treated in ambulatory regimen." European Respiratory Journal 21.5 (2003): 785-788. Web. 27 June. 2022.

  8. Rosenthal, M.

    1. Chavasse, R. et al "To clip or not to clip? Noseclips for spirometry." European Respiratory Journal 21.5 (2003): 876-878. Web. 27 June. 2022.

S

  1. Santos, S.

    1. Barberà, J.A., V.I. Peinado, and S. Santos. "Pulmonary hypertension in chronic obstructive pulmonary disease." European Respiratory Journal 21.5 (2003): 892-905. Web. 27 June. 2022.

  2. Scherrer, U.

    1. Cook, S. et al "Increased eNO and pulmonary iNOS expression in eNOS null mice." European Respiratory Journal 21.5 (2003): 770-773. Web. 27 June. 2022.

  3. Schulte, N.A.

    1. Ediger, T.L. et al "Transcription factor activation and mitogenic synergism in airway smooth muscle cells." European Respiratory Journal 21.5 (2003): 759-769. Web. 27 June. 2022.

  4. Sculier, J.P.

    1. Mascaux, C. et al "Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53." European Respiratory Journal 21.5 (2003): 753-758. Web. 27 June. 2022.

  5. Shimizu, T.

    1. Nishigaki, Y. et al "Increased vascular endothelial growth factor in acute eosinophilic pneumonia." European Respiratory Journal 21.5 (2003): 774-778. Web. 27 June. 2022.

  6. Sommerfeld, C.

    1. Lau, S. et al "Transient early wheeze is not associated with impaired lung function in 7‐yr-old children." European Respiratory Journal 21.5 (2003): 834-841. Web. 27 June. 2022.

  7. Splettstoesser, T.

    1. Büttner, C. et al "Monoclonal anti-interleukin‐5 treatment suppresses eosinophil but not T‐cell functions." European Respiratory Journal 21.5 (2003): 799-803. Web. 27 June. 2022.

  8. Stempel, D.A.

    1. Stempel, D.A.. "Asthma variability." European Respiratory Journal 21.5 (2003): 909-910. Web. 27 June. 2022.

T

  1. Takahashi, M.

    1. Hoshino, M. et al "Increased immunoreactivity of stromal cell-derived factor‐1 and angiogenesis in asthma." European Respiratory Journal 21.5 (2003): 804-809. Web. 27 June. 2022.

  2. Takeda, A.

    1. Nishigaki, Y. et al "Increased vascular endothelial growth factor in acute eosinophilic pneumonia." European Respiratory Journal 21.5 (2003): 774-778. Web. 27 June. 2022.

  3. Talas, D.U.

    1. Nayci, A. et al "Rigid bronchoscopy induces bacterial translocation: an experimental study in rats." European Respiratory Journal 21.5 (2003): 749-752. Web. 27 June. 2022.

  4. Taylor, D.R.

    1. Wraight, J.M. et al "Bronchodilator tolerance: the impact of increasing bronchoconstriction." European Respiratory Journal 21.5 (2003): 810-815. Web. 27 June. 2022.

  5. Thompson, M.L.

    1. Labiris, N.R. et al "Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?." European Respiratory Journal 21.5 (2003): 848-854. Web. 27 June. 2022.

  6. Toews, M.L.

    1. Ediger, T.L. et al "Transcription factor activation and mitogenic synergism in airway smooth muscle cells." European Respiratory Journal 21.5 (2003): 759-769. Web. 27 June. 2022.

  7. Torres, A.

    1. Woodhead, M., S. Ewig, and A. Torres. "Severe acute respiratory syndrome (SARS)." European Respiratory Journal 21.5 (2003): 739-740. Web. 27 June. 2022.
    2. Ewig, S., and A. Torres. "Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?." European Respiratory Journal 21.5 (2003): 741-742. Web. 27 June. 2022.

  8. Tortolero, S.R.

    1. Arif, A.A. et al "Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data." European Respiratory Journal 21.5 (2003): 827-833. Web. 27 June. 2022.

  9. Troosters, T.

    1. Rabinovich, R.A. et al "Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients." European Respiratory Journal 21.5 (2003): 789-794. Web. 27 June. 2022.

V

  1. van der Ent, C.K.

    1. Gracchi, V. et al "Spirometry in young children: should computer-animation programs be used during testing?." European Respiratory Journal 21.5 (2003): 872-875. Web. 27 June. 2022.

  2. van der Laag, J.

    1. Gracchi, V. et al "Spirometry in young children: should computer-animation programs be used during testing?." European Respiratory Journal 21.5 (2003): 872-875. Web. 27 June. 2022.

  3. Van Herreweghe, R.

    1. Meysman, M. et al "Recurrent tracheal mass." European Respiratory Journal 21.5 (2003): 906-908. Web. 27 June. 2022.

  4. van Kaam, A.H.

    1. Dik, W.A. et al "Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity." European Respiratory Journal 21.5 (2003): 842-847. Web. 27 June. 2022.

  5. Vehmas, T.

    1. Vehmas, T. et al "Effects of tobacco smoking on findings in chest computed tomography among asbestos-exposed workers." European Respiratory Journal 21.5 (2003): 866-871. Web. 27 June. 2022.

  6. Verdebout, J.M.

    1. Mascaux, C. et al "Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53." European Respiratory Journal 21.5 (2003): 753-758. Web. 27 June. 2022.

  7. Versnel, M.A.

    1. Dik, W.A. et al "Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity." European Respiratory Journal 21.5 (2003): 842-847. Web. 27 June. 2022.

  8. Vestbo, J.

    1. Prescott, E. et al "Social position and mortality from respiratory diseases in males and females." European Respiratory Journal 21.5 (2003): 821-826. Web. 27 June. 2022.

  9. Vincken, W.

    1. Meysman, M. et al "Recurrent tracheal mass." European Respiratory Journal 21.5 (2003): 906-908. Web. 27 June. 2022.

  10. Völkel, K.

    1. Lau, S. et al "Transient early wheeze is not associated with impaired lung function in 7‐yr-old children." European Respiratory Journal 21.5 (2003): 834-841. Web. 27 June. 2022.

  11. Vollenweider, P.

    1. Cook, S. et al "Increased eNO and pulmonary iNOS expression in eNOS null mice." European Respiratory Journal 21.5 (2003): 770-773. Web. 27 June. 2022.

W

  1. Wahn, U.

    1. Lau, S. et al "Transient early wheeze is not associated with impaired lung function in 7‐yr-old children." European Respiratory Journal 21.5 (2003): 834-841. Web. 27 June. 2022.

  2. Whitehead, L.W.

    1. Arif, A.A. et al "Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data." European Respiratory Journal 21.5 (2003): 827-833. Web. 27 June. 2022.

  3. Woodhead, M.

    1. Woodhead, M., S. Ewig, and A. Torres. "Severe acute respiratory syndrome (SARS)." European Respiratory Journal 21.5 (2003): 739-740. Web. 27 June. 2022.

  4. Wraight, J.M.

    1. Wraight, J.M. et al "Bronchodilator tolerance: the impact of increasing bronchoconstriction." European Respiratory Journal 21.5 (2003): 810-815. Web. 27 June. 2022.

Y

  1. Yamazaki, Y.

    1. Nishigaki, Y. et al "Increased vascular endothelial growth factor in acute eosinophilic pneumonia." European Respiratory Journal 21.5 (2003): 774-778. Web. 27 June. 2022.

  2. Yu, C.

    1. Zhang, J. et al "From the Authors." European Respiratory Journal 21.5 (2003): 910. Web. 27 June. 2022.

Z

  1. Zhang, J.

    1. Zhang, J. et al "From the Authors." European Respiratory Journal 21.5 (2003): 910. Web. 27 June. 2022.

  2. Zimmermann, L.J.I.

    1. Dik, W.A. et al "Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity." European Respiratory Journal 21.5 (2003): 842-847. Web. 27 June. 2022.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts